176 related articles for article (PubMed ID: 38028545)
1. High-throughput quantitation of amino acids and acylcarnitine in cerebrospinal fluid: identification of PCNSL biomarkers and potential metabolic messengers.
Ma J; Chen K; Ding Y; Li X; Tang Q; Jin B; Luo RY; Thyparambil S; Han Z; Chou CJ; Zhou A; Schilling J; Lin Z; Ma Y; Li Q; Zhang M; Sylvester KG; Nagpal S; McElhinney DB; Ling XB; Chen B
Front Mol Biosci; 2023; 10():1257079. PubMed ID: 38028545
[No Abstract] [Full Text] [Related]
2. Cerebrospinal fluid-based metabolomics to characterize different types of brain tumors.
Wang FX; Chen K; Huang FQ; Alolga RN; Ma J; Wu ZX; Fan Y; Ma G; Guan M
J Neurol; 2020 Apr; 267(4):984-993. PubMed ID: 31822990
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment.
Zhou L; Li Q; Xu J; Wang S; Song Z; Chen X; Ma Y; Lin Z; Chen B; Huang H
Neurooncol Adv; 2023; 5(1):vdac181. PubMed ID: 36879663
[TBL] [Abstract][Full Text] [Related]
4. Phosphoproteome analysis of cerebrospinal fluid extracellular vesicles in primary central nervous system lymphoma.
Deng Y; Li Q; Sun J; Ma L; Ding Y; Cai Y; Iliuk A; Chen B; Xie Z; Tao WA
Analyst; 2023 Jul; 148(15):3594-3602. PubMed ID: 37403840
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
Li J; Tang X; Luo X; Liu L; Li D; Yang L
Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
[TBL] [Abstract][Full Text] [Related]
6. A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry.
Waldera-Lupa DM; Poschmann G; Kirchgaessler N; Etemad-Parishanzadeh O; Baberg F; Brocksieper M; Seidel S; Kowalski T; Brunn A; Haghikia A; Gold R; Stefanski A; Deckert M; Schlegel U; Stühler K
Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32610669
[TBL] [Abstract][Full Text] [Related]
7. High Level of IL-10 in Cerebrospinal Fluid is Specific for Diagnosis of Primary Central Nervous System Lymphoma.
Shao J; Chen K; Li Q; Ma J; Ma Y; Lin Z; Kang H; Chen B
Cancer Manag Res; 2020; 12():6261-6268. PubMed ID: 32801871
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic role and dynamic changes in cerebrospinal fluid neopterin during treatment of patients with primary central nervous system lymphoma.
Geng M; Xiao H; Liu J; Song Y; Fu P; Cheng X; Zhang J; Wang G
Cancer Med; 2018 Aug; 7(8):3889-3898. PubMed ID: 29982995
[TBL] [Abstract][Full Text] [Related]
9. Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas.
Zajdel M; Rymkiewicz G; Sromek M; Cieslikowska M; Swoboda P; Kulinczak M; Goryca K; Bystydzienski Z; Blachnio K; Ostrowska B; Borysiuk A; Druzd-Sitek A; Walewski J; Chechlinska M; Siwicki JK
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31731456
[TBL] [Abstract][Full Text] [Related]
10. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma.
Baraniskin A; Zaslavska E; Nöpel-Dünnebacke S; Ahle G; Seidel S; Schlegel U; Schmiegel W; Hahn S; Schroers R
Neuro Oncol; 2016 Mar; 18(3):361-7. PubMed ID: 26250566
[TBL] [Abstract][Full Text] [Related]
11. The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.
Hottenrott T; Schorb E; Fritsch K; Dersch R; Berger B; Huzly D; Rauer S; Tebartz van Elst L; Endres D; Stich O
J Neurol; 2018 May; 265(5):1106-1114. PubMed ID: 29511863
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo NMR metabolomics approach using cerebrospinal fluid for the diagnosis of primary CNS lymphoma: Correlation with MR imaging characteristics.
Kim JH; An YJ; Kim TM; Kim JE; Park S; Choi SH
Cancer Med; 2023 Feb; 12(4):4679-4689. PubMed ID: 35941814
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma.
Hu Y; Zhang Q; Wu Z; Chen K; Xu X; Ma W; Chen B; Jin L; Guan M
Discov Oncol; 2023 Nov; 14(1):205. PubMed ID: 37971595
[TBL] [Abstract][Full Text] [Related]
14. MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
Ferreri AJM; Calimeri T; Lopedote P; Francaviglia I; Daverio R; Iacona C; Belloni C; Steffanoni S; Gulino A; Anghileri E; Diffidenti A; Finardi A; Gagliardi F; Anzalone N; Nonis A; Furlan R; De Lorenzo D; Terreni MR; Martinelli V; Sassone M; Foppoli M; Angelillo P; Guggiari E; Falini A; Mortini P; Filippi M; Tarantino V; Eoli M; Ciceri F; Doglioni C; Tripodo C; Locatelli M; Cangi MG; Ponzoni M
Br J Haematol; 2021 May; 193(3):497-505. PubMed ID: 33620087
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid soluble programmed death-ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma.
Cheng CL; Yao CY; Huang PH; Yu CW; Fang WQ; Chuang WH; Wu SJ; Lin YJ; Hung YC; Tsai CH; Yu SC; Chou WC; Tien HF
Br J Haematol; 2023 Apr; 201(1):75-85. PubMed ID: 36480431
[TBL] [Abstract][Full Text] [Related]
16. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS.
Baraniskin A; Chomiak M; Ahle G; Gress T; Buchholz M; Turewicz M; Eisenacher M; Margold M; Schlegel U; Schmiegel W; Hahn S; Schroers R
J Neurooncol; 2018 May; 137(3):463-468. PubMed ID: 29327175
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma.
Baraniskin A; Kuhnhenn J; Schlegel U; Schmiegel W; Hahn S; Schroers R
J Neurooncol; 2012 Sep; 109(2):239-44. PubMed ID: 22729947
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma.
Song Y; Zhang W; Zhang L; Wu W; Zhang Y; Han X; Yang C; Zhang L; Zhou D
Sci Rep; 2016 Dec; 6():38671. PubMed ID: 27924864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
